These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38958114)

  • 1. Growth Hormone Treatment in Children of Normal Height.
    Mendonca BB; Arnhold IJP
    J Clin Endocrinol Metab; 2024 Jul; ():. PubMed ID: 38958114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth velocity, final height and bone mineral metabolism of short children treated long term with growth hormone.
    Lanes R
    Curr Pharm Biotechnol; 2000 Jul; 1(1):33-46. PubMed ID: 11467359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current indications for growth hormone therapy for children and adolescents.
    Richmond E; Rogol AD
    Endocr Dev; 2010; 18():92-108. PubMed ID: 20523020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the exon 3-deleted growth hormone (GH) receptor polymorphism on baseline height and the growth response to recombinant human GH therapy in GH-deficient (GHD) and non-GHD children with short stature: a systematic review and meta-analysis.
    Wassenaar MJ; Dekkers OM; Pereira AM; Wit JM; Smit JW; Biermasz NR; Romijn JA
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3721-30. PubMed ID: 19584188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant growth hormone for idiopathic short stature in children and adolescents.
    Bryant J; Baxter L; Cave CB; Milne R
    Cochrane Database Syst Rev; 2007 Jul; (3):CD004440. PubMed ID: 17636758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children.
    Binder G; Baur F; Schweizer R; Ranke MB
    J Clin Endocrinol Metab; 2006 Feb; 91(2):659-64. PubMed ID: 16291706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results of growth hormone therapy in children with short stature, subnormal growth rate and normal growth hormone response to secretagogues. Dutch Growth Hormone Working Group.
    Wit JM; Boersma B; de Muinck Keizer-Schrama SM; Nienhuis HE; Oostdijk W; Otten BJ; Delemarre-Van de Waal HA; Reeser M; Waelkens JJ; Rikken B
    Clin Endocrinol (Oxf); 1995 Apr; 42(4):365-72. PubMed ID: 7750190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Responses to growth hormone (GH) therapy in short children with normal GH secretion and no bone age delay: an analysis of potential factors affecting their response to rhGH therapy. A controlled study.
    Soliman AT; Elawwa A; Itani M; Jour C; De Sanctis V
    Acta Biomed; 2019 Sep; 90(8-S):43-51. PubMed ID: 31544806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized pilot trial of growth hormone with anastrozole versus growth hormone alone, starting at the very end of puberty in adolescents with idiopathic short stature.
    Rothenbuhler A; Linglart A; Bougnères P
    Int J Pediatr Endocrinol; 2015; 2015(1):4. PubMed ID: 25972902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS AND PATIENTS TRANSITIONING FROM PEDIATRIC TO ADULT CARE.
    Yuen KCJ; Biller BMK; Radovick S; Carmichael JD; Jasim S; Pantalone KM; Hoffman AR
    Endocr Pract; 2019 Nov; 25(11):1191-1232. PubMed ID: 31760824
    [No Abstract]   [Full Text] [Related]  

  • 11. Real-life long-term efficacy and safety of recombinant human growth hormone therapy in children with short stature homeobox-containing deficiency.
    Bruzzi P; Vannelli S; Scarano E; Di Iorgi N; Parpagnoli M; Salerno M; Pitea M; Elisabeth Street M; Secco A; Andrea Trettene A; Wasniewska M; Corciulo N; Tornese G; Felicia Faienza M; Delvecchio M; Filomena Madeo S; Iughetti L
    Endocr Connect; 2023 Jul; 12(7):. PubMed ID: 37014306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human growth hormone for the treatment of growth disorders in children: a systematic review and economic evaluation.
    Takeda A; Cooper K; Bird A; Baxter L; Frampton GK; Gospodarevskaya E; Welch K; Bryant J
    Health Technol Assess; 2010 Sep; 14(42):1-209, iii-iv. PubMed ID: 20849734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human growth hormone plus recombinant human insulin-like growth factor-1 coadministration therapy in short children with low insulin-like growth factor-1 and growth hormone sufficiency: results from a randomized, multicenter, open-label, parallel-group, active treatment-controlled trial.
    Backeljauw PF; Miller BS; Dutailly P; Houchard A; Lawson E; Hale DE; Reiner B; Sperling MA;
    Horm Res Paediatr; 2015; 83(4):268-79. PubMed ID: 25765099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of children born small for gestational age with short stature who qualify for growth hormone treatment.
    Tamaro G; Pizzul M; Gaeta G; Servello R; Trevisan M; Böhm P; Materassi PMA; Macaluso A; Valentini D; Pellegrin MC; Barbi E; Tornese G
    Ital J Pediatr; 2021 Apr; 47(1):82. PubMed ID: 33794966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inside the Noonan "universe": Literature review on growth, GH/IGF axis and rhGH treatment: Facts and concerns.
    Stagi S; Ferrari V; Ferrari M; Priolo M; Tartaglia M
    Front Endocrinol (Lausanne); 2022; 13():951331. PubMed ID: 36060964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of growth hormone therapy on height in children with idiopathic short stature: a meta-analysis.
    Finkelstein BS; Imperiale TF; Speroff T; Marrero U; Radcliffe DJ; Cuttler L
    Arch Pediatr Adolesc Med; 2002 Mar; 156(3):230-40. PubMed ID: 11876666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The growth hormone cascade: progress and long-term results of growth hormone treatment in growth hormone deficiency.
    Grumbach MM; Bin-Abbas BS; Kaplan SL
    Horm Res; 1998; 49 Suppl 2():41-57. PubMed ID: 9730672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant growth hormone for idiopathic short stature in children and adolescents.
    Bryant J; Cave C; Milne R
    Cochrane Database Syst Rev; 2003; (4):CD004440. PubMed ID: 14584015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
    Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant growth hormone improves growth and adult height in patients with maternal inactivating GNAS mutations.
    Ertl DA; de Nanclares GP; Jüppner H; Hanna P; Pagnano A; Pereda A; Rothenbuhler A; Del Sindaco G; Ruiz-Cuevas P; Audrain C; Escribano A; Berkenou J; Gleiss A; Mantovani G; Linglart A
    Eur J Endocrinol; 2023 Jul; 189(1):123-131. PubMed ID: 37440712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.